Status:
RECRUITING
68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases
Lead Sponsor:
University Hospital, Brest
Conditions:
Inflammatory Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This single-center pilot study is designed to explore the preliminary utility of the \[68Ga\] Ga-FAPI imaging agent in positron emission tomography (PET) combined with computed tomography (CT) for a r...
Detailed Description
\[68Ga\] Ga-FAPI is an innovative radiotracer in positron emission tomography (PET) coupled to scanner (CT: computed tomography). It targets the membrane glycoprotein FAP (Fibroblast Activation Protei...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
March 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 21 2027
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT06275477
Start Date
March 13 2025
End Date
September 21 2027
Last Update
March 4 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29200